We are pleased to announce that ExoPolymer has been awarded a Phase I SBIR grant from the USDA. This non equity funding will help us develop robust fermentation processes and map rheological performance of our next generation hydrocolloids. We are eager to start work on the project and generate important data for our strains and products!
ExoPolymer, a biotechnology company that specializes in next generation biopolymers for the healthcare, personal care, and food markets, is pleased to announce the first major participant in our Seed funding round, the Investment Group of Santa Barbara (IGSB). IGSB has funded a diverse set of companies in their portfolio and has a strong track record of success. Their early participation will allow ExoPolymer to expand operations and to conduct specific research activities for our first target market.
ExoPolymer produces new and improved biopolymers, or hydrocolloids, using our proprietary biological production systems. Our products have differential performance in comparison to incumbent molecules such as xanthan, guar, and gellan gums, and the potential to expand hydrocolloid use in a diverse array of markets.
We are excited to have IGSB as an investor and we look forward to continuing our momentum into the new year!
At the BIO World Congress on Industrial Biotechnology and AgTech in Des Moines, Iowa, the National Corn Growers Association (NCGA) announced the winners of the Consider Corn Challenge II. Three winners were chosen, each with a unique technology to improve a product or process using field corn to produce biobased materials.
“Corn is a sustainable, abundant and affordable industrial feedstock that, as these companies have demonstrated, has myriad uses,” said Director of Market Development Sarah McKay. “The winners of the Consider Corn Challenge will help America’s corn farmers partner with industry to establish new uses of corn. This challenge continues to highlight the fact that U.S. corn is an extremely flexible feedstock for biobased products.”